Let's Talk ID cover image

The Latest on COVID-19 Treatments (March 12, 2022)

Let's Talk ID

00:00

Is There a Broader Window for Treating Unono Compromise?

Are these therapies that we've been discussing to day going to keep up with the coved 19 variants? Maybe i'll start, and then i'll m turn it over to doctor bimroge for his perspectives. So i think it depends on the the variant and the drug. The small molecule anti varls the matver, rotanver, remdesver, moluperver all of those are active against b a two. But there is some concern that b a two may be less susceptible to strovemab based on laboratory testing. And so for that reason, panel advises that baptilovo mab should only be used in high risk individuals.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app